• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法律诉讼:制药行业在巴西公共医疗体系引入新药的策略。

Legal suits: pharmaceutical industry strategies to introduce new drugs in the Brazilian public healthcare system.

机构信息

Secretaria de Estado da Saúde, São Paulo, SP, Brazil.

出版信息

Rev Saude Publica. 2010 Jun;44(3):421-8. doi: 10.1590/s0034-89102010000300005.

DOI:10.1590/s0034-89102010000300005
PMID:20549017
Abstract

OBJECTIVE

To assess the distribution rate of legal suits according to drug (manufacturer), prescribing physician, and attorney filing the lawsuit.

METHODS

A descriptive study was carried out to assess the lawsuits in the São Paulo State (Southeastern Brazil) courts registry in 2006, and amounts spent in complying with these lawsuits, and total costs with medication thus resulting.

RESULTS

In 2006, the São Paulo State Administration spent 65 million Brazilian reais in compliance with court decisions to provide medication to approximately 3,600 individuals. The total cost of the medication was 1.2 billion Brazilian reais. In the period studied, 2,927 lawsuits were examined. These lawsuits were filed by 565 legal professionals, among which 549 were attorneys engaged by private individuals (97.17% of the total legal professionals). The drugs scope of the lawsuits had been prescribed by 878 different physicians. By assessing the number of lawsuits filed per attorney, it was found that 35% of them were brought before the courts by 1% of them.

CONCLUSIONS

The data related to the lawsuits and to the medication classified according to manufacturer, show that a small number of attorneys is responsible for the largest number of lawsuits filed to obtain these drugs. The finding that more than 70% of the lawsuits filed for certain drugs are the responsibility of one single attorney, may suggest a close connection between this professional and the manufacturer.

摘要

目的

根据药物(制造商)、处方医生和提起诉讼的律师评估法律诉讼的分布率。

方法

本研究为描述性研究,旨在评估 2006 年巴西圣保罗州(东南部)法院诉讼登记处的诉讼情况,以及为遵守这些诉讼而支出的款项,以及由此产生的药物总费用。

结果

2006 年,巴西圣保罗州行政部门花费 6500 万雷亚尔来遵守法院判决,为大约 3600 人提供药物。药物总成本为 12 亿雷亚尔。在研究期间,共审查了 2927 起诉讼。这些诉讼由 565 名法律专业人员提起,其中 549 名是私人律师(占法律专业人员总数的 97.17%)。诉讼涉及的药物是由 878 名不同的医生开具的。通过评估每位律师提起的诉讼数量,发现其中 35%的诉讼是由 1%的律师提起的。

结论

根据制造商对诉讼和药物进行分类的数据表明,少数律师负责提起了大部分获取这些药物的诉讼。对于某些药物,超过 70%的诉讼由一名律师负责,这可能表明该专业人员与制造商之间存在密切联系。

相似文献

1
Legal suits: pharmaceutical industry strategies to introduce new drugs in the Brazilian public healthcare system.法律诉讼:制药行业在巴西公共医疗体系引入新药的策略。
Rev Saude Publica. 2010 Jun;44(3):421-8. doi: 10.1590/s0034-89102010000300005.
2
Legal access to medications: a threat to Brazil's public health system?药品的合法获取:对巴西公共卫生系统的威胁?
BMC Health Serv Res. 2017 Jul 19;17(1):499. doi: 10.1186/s12913-017-2430-x.
3
[Doctors, lawyers and pharmaceutical industry on health lawsuits in Minas Gerais, Southeastern Brazil].[巴西东南部米纳斯吉拉斯州医生、律师与制药行业在健康诉讼方面的情况]
Rev Saude Publica. 2012 Oct;46(5):784-90. doi: 10.1590/s0034-89102012000500004.
4
Legal and health variations in drug litigation injunctions granted in Minas Gerais.米纳斯吉拉斯州批准的药物诉讼禁令中的法律和健康差异。
Rev Saude Publica. 2014 Oct;48(5):808-16. doi: 10.1590/s0034-8910.2014048005286.
5
Rational use of anticancer drugs and patient lawsuits in the state of São Paulo, Southeastern Brazil.巴西东南部圣保罗州抗癌药物的合理使用与患者诉讼
Rev Saude Publica. 2010 Aug;44(4):620-8. doi: 10.1590/s0034-89102010000400005.
6
[Distortions to national drug policy caused by lawsuits in Brazil].[巴西诉讼对国家药物政策造成的扭曲]
Rev Saude Publica. 2007 Apr;41(2):214-22. doi: 10.1590/s0034-89102007000200007.
7
Between the court and the clinic: lawsuits for medicines and the right to health in Brazil.法庭与诊所之间:巴西的药品诉讼与健康权
Health Hum Rights. 2012 Jun 15;14(1):E36-52.
8
[Safeguarding of the social right to pharmaceutical assistance in the state of São Paulo, Brazil].[巴西圣保罗州药品援助社会权利的保障]
Rev Saude Publica. 2007 Feb;41(1):101-7. doi: 10.1590/s0034-89102007000100014.
9
[Can court injunctions guarantee access to medicines in the public sector? The experience in the State of Rio de Janeiro, Brazil].[法院禁令能保障公共部门的药品获取吗?巴西里约热内卢州的经验]
Cad Saude Publica. 2005 Mar-Apr;21(2):525-34. doi: 10.1590/s0102-311x2005000200019. Epub 2005 Mar 21.
10
Studies published in indexed journals on lawsuits for medicines in Brazil: a systematic review.发表于索引期刊上的关于巴西药品诉讼的研究:一项系统综述。
Cad Saude Publica. 2015 Mar;31(3):451-62. doi: 10.1590/0102-311x00219113.

引用本文的文献

1
Variability in public procurement prices for Group 1A drugs in the specialized pharmaceutical component: an observational study, 2013-2022.2013 - 2022年专科药品成分中1A组药物公共采购价格的差异:一项观察性研究
Epidemiol Serv Saude. 2025 Sep 1;34:e20240733. doi: 10.1590/S2237-96222025v34e20240733.en. eCollection 2025.
2
Judicialization of Zolgensma in the Ministry of Health: costs and clinical profile of patients.将 Zolgensma 纳入卫生部的司法化:患者的成本和临床特征。
Rev Saude Publica. 2024 Aug 12;58:36. doi: 10.11606/s1518-8787.2024058005899. eCollection 2024.
3
Data Sources for Drug Utilization Research in Brazil-DUR-BRA Study.
巴西药物利用研究的数据来源——DUR-BRA研究
Front Pharmacol. 2022 Jan 14;12:789872. doi: 10.3389/fphar.2021.789872. eCollection 2021.
4
Judicialization of medicines: effectiveness of rights or break in public policies?医药的司法化:权利的有效性还是公共政策的断裂?
Rev Saude Publica. 2020 Dec 14;54:130. doi: 10.11606/s1518-8787.2020054002301. eCollection 2020.
5
The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health.依库珠单抗案例:法律诉讼和巴西卫生部的采购。
Rev Saude Publica. 2020 Mar 2;54:22. doi: 10.11606/s1518-8787.2020054001693. eCollection 2020.
6
Judicial demand of medications through the Federal Justice of the State of Paraná.通过巴拉那州联邦法院对药物的司法需求。
Einstein (Sao Paulo). 2017 Jan-Mar;15(1):85-91. doi: 10.1590/S1679-45082017GS3792.
7
The Judicialization of Health and the Quest for State Accountability: Evidence from 1,262 Lawsuits for Access to Medicines in Southern Brazil.健康的司法化与对国家问责制的追求:来自巴西南部1262起获取药品诉讼的证据
Health Hum Rights. 2016 Jun;18(1):209-220.
8
Prioritization of strategies to approach the judicialization of health in Latin America and the Caribbean.拉丁美洲和加勒比地区应对卫生司法化问题的策略优先次序
Rev Saude Publica. 2016 Sep 1;50:56. doi: 10.1590/S1518-8787.2016050005728.
9
Health and Ethical Consequences of Outsourcing Pivotal Clinical Trials to Latin America: A Cross-Sectional, Descriptive Study.将关键临床试验外包至拉丁美洲的健康与伦理后果:一项横断面描述性研究
PLoS One. 2016 Jun 23;11(6):e0157756. doi: 10.1371/journal.pone.0157756. eCollection 2016.
10
Economic evaluations in gastroenterology in Brazil: A systematic review.巴西胃肠病学领域的经济学评估:一项系统综述。
World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):162-70. doi: 10.4292/wjgpt.v7.i1.162.